CHICAGO HIGHLIGHTS 2024 – BREAST ROUNDTABLE DISCUSSION: I-SPY 2.2
OR
Chair
Dr. Christine Simmons
Panelists
Dr. Christine Brezden-Masley
Dr. Heather McArthur
This program has been made possible through unrestricted support from Eli Lilly
Studies/trials discussed:
- I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer
